HYPO LENZB N/ CH0001341608 /
14/01/2025 12:03:16 | Chg. - | Volume | Bid09:38:46 | Demandez à09:38:46 | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
4,040.00CHF | - | 23 Chiffrre d'affaires: 93,380 |
4,040.00Bid taille: 3 | 4,080.00Ask la taille: 6 | 290.88 Mio.CHF | 2.97% | 13.75 |
Newsfile Corp
05:37
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Impo...
Newsfile Corp
05:26
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Be...
Newsfile Corp
04:10
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page